RPG Life Sciences Limited (BOM:532983)
2,805.60
-20.50 (-0.73%)
At close: Sep 18, 2026
RPG Life Sciences Market Cap
RPG Life Sciences has a market cap or net worth of 46.35 billion as of September 18, 2026. Its market cap has increased by 16.80% in one year.
Market Cap
46.35B
Enterprise Value
43.81B
Revenue
7.34B
Ranking
n/a
PE Ratio
38.74
Stock Price
2,805.60
ChartMarket Cap Chart
Since June 10, 2008, RPG Life Sciences's market cap has increased from 645.16M to 46.35B, an increase of 7,084.08%. That is a compound annual growth rate of 26.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 46.35B | 20.67% |
| Dec 31, 2025 | 38.41B | 6.31% |
| Dec 31, 2024 | 36.13B | 63.53% |
| Dec 29, 2023 | 22.09B | 57.71% |
| Dec 30, 2022 | 14.01B | 37.00% |
| Dec 31, 2021 | 10.23B | 67.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Procter & Gamble Health | 91.33B |
| Bliss GVS Pharma | 72.31B |
| Sanofi India | 71.12B |
| Morepen Laboratories | 66.25B |
| FDC Limited | 57.14B |
| Novartis India | 50.80B |
| Gufic Biosciences | 43.68B |
| Unichem Laboratories | 38.41B |